%0 Letter
%T Letter to the editor regarding "Induction chemotherapy regimes in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: A network meta-analysis and cost-effectiveness analysis.
%A Ganesh PS
%A Pathoor NN
%A Gopal RK
%J Oral Oncol
%V 157
%N 0
%D 2024 Oct 23
%M 39047541
%F 5.972
%R 10.1016/j.oraloncology.2024.106954
%X The research paper offers a detailed analysis of induction chemotherapy regimens for locoregionally advanced nasopharyngeal carcinoma (LA-NPC), assessing their effectiveness and cost-effectiveness. It presents important data on disease-free survival and overall survival outcomes. However, this letter suggests several improvements. It advocates for the inclusion of patient-centered outcomes such as quality of life and functional status to better gauge treatment impacts on daily living. Additionally, it calls for a more thorough investigation into long-term adverse effects and the role of biomarkers in tailoring treatments. It also recommends a comparative analysis of cost-effectiveness across various healthcare systems and the creation of practical guidelines for regimen selection. These proposed changes aim to enhance the study's practical relevance and clinical applicability.